FDA Approves GSK’s RSV Vaccine for Older Adults
HealthApproval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says Source link
UK:GSK
Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults
The company said it would apply in coming months for U.S. regulatory approval. Source link
Merck Is Coming for Pfizer’s Pneumonia Vaccine Market Share
HealthRivals’ interest in the $7 billion market shows the drug industry’s renewed focus on vaccines Source link
U.K. Approves Covid-19 Booster Shot Aimed at Omicron
The U.K. became the first country to approve Moderna Inc.’s Omicron-targeting Covid-19 vaccine as a booster shot, paving the way...
